PERIOD OF INFECTIVITY OF PATIENTS WITH HOMOLOGOUS SERUM JAUNDICE AND ROUTES OF INFECTION IN THIS DISEASE by Havens, W. Paul
PERIOD  OF  INFECTIVITY  OF  PATIENTS  WITH  HOMOLOGOUS 
SERUM  JAUNDICE  AND  ROUTES  OF  INFECTION 
IN  THIS  DISEASE* 
BY W. PAUL HAVENS, J2.,  M.D. 
(Front the. Section of Preventive Medicine,  Yale University School of Medicine, 
New Ha~en) 
(Received for publication,  March 5, 1946) 
In a preceding paper (1)  the period of infectivity in infectious hepatitis has 
been studied.  In the present paper the same type of study has been made in 
cases of homologous serum jaundice.  Primarily it is important that a distinc- 
tion be made between these two conditions.  This distinction is not easy for it 
is quite possible that serum jaundice and infectious hepatitis may not only be 
closely related but confused, in that the former may occasionally represent the 
artificial production of the latter.  Nevertheless, while the artificial production 
of infectious hepatitis may be true in some instances, it cannot yet be said that 
all serum jaundice belongs in this category.  Thus it is the belief expressed in 
previous papers from this laboratory (2, 3) and elsewhere (4-6)  that the two 
conditions may actually be different.  Neefe, Stokes, and Gellis (7)  have re- 
cently summarized certain of the differences and similarities between  them. 
At present however, the definition of homologous serum jaundice is an artificial 
one: it may be described arbitrarily as a form of hepatitis ordinarily produced 
by  the  parenteral  inoculation of human  blood  products  obtained  from an 
individual who, though not apparently ill, is carrying the causative icterogenic 
agent in his blood (2).  Large numbers of cases have been produced in individu- 
als who have been injected with human immune serum (8-10), with vaccines 
containing human serum (11-13), and with whole blood or plasma (14-16). 
Considerable new information has been made available by the experimental 
transmission of homologous serum jaundice to human volunteers (2, 5, 7, 17, 
18).  It has been found that the etiologic agent (in serum) is filtrable, resistant 
to a  temperature of 56°C. for at least 60 minutes, and is transmissible to man 
in serial passage.  This agent is believed to be a virus and like  the  agent of 
infectious hepatitis it has not been transmitted to laboratory animals or grown 
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in tissue culture (13, 17,19).  It has been detected in the serum of patients early 
in the incubation period (2) as well as in the acute phase of the disease and in 
practically all known instances has been transmitted to'man by parenteral inocu- 
lation.  Reports of the infectivity of nasopharyngeal washings of patients in 
the acute phase of disease have appeared but the evidence for positive results 
has been meagre (19).  Recent attempts by Neefe and Stokes (20) to recover 
virus from the stools of patients in the acute phase of homologous serum jaun- 
dice have been unsuccessful.  Moreover, with  the exception of one case of 
experimental infection (18) of a human volunteer by feeding infectious serum, 
this disease has not been transmitted experimentally by the oral route,  a 
Experiments in the transmission  of homologous serum jaundice to human 
volunteers have employed serum obtained from patients during the incubation 
period as well as the acute phase of the disease.  Thus it has already been dem- 
onstrated in this laboratory that virus may be present in the circulating blood 
of an apparently well human volunteer 34 days after experimental inoculation 
with a  strain of homologous serum jaundice and 60 days before onset of his 
disease (2).  Little is known, however, as to the limits of the infective period. 
Oliphant (17) has reported that the blood of patients convalescent from serum 
jaundice was no longer infectious 2t months after disappearance of jaundice 
when inoculated into human volunteers. 
It is the purpose of the following experiment to determine: (1) the period of 
infectivity of patients with experimentally induced homologous serum jaundice; 
(2) the infectivity of stools of patients in the acute phase of serum jaundice; and 
(3) whether serum jaundice can be produced in human volunteers by ingestion 
of serum known to be infectious. 
Materials and Methods 
Subjects.m29 male human volunteers varying in age from 21 to 41 years were employed am 
experimental subjects; they were all housed in the same institution.  All subjects were fol- 
lowed for 135 days after inoculation and were instructed to report at once the occurrence of 
any symptoms, which were then investigated. 
Virus.raThe strain of homologous serum jaundice virus used in this laboratory was origi- 
nally derived from a serum pool collected by Lieutenant Colonel A. B. Sabin from British and 
I During early transmission experiments in this laboratory (21) a mixed pool of serum ob- 
tained from 3 patients with homologous serum jaundice  and I patient with infectious hepatitis, 
produced hepatitis in 3 human volunteers following ingestion.  This is believed to represent • 
transmission of infectious hepatitis rather than homologous serum jaundice, for the following 
reasons: (I) repeated attempts to infect human volunteers by feeding infectious material simi- 
lar to the homologous serum jaundice component of the pool have failed, while parenteral 
inoculation of the same material has been successful in transmitting this disease; (2) feeding 
infectious material similar to the infectious hepatitis component of the pool has regularly 
produced this disease in human volunteers; (3)patients convalescent from homologous serum 
jaundice induced by parenteral inoculation  of that component of the pool are not immune to 
reinoculation  with the infectious  hepatitis component of the pool (3). W.  PAUL  HAVENS,  JR.  443 
American troops in the course of studies on sand-fy fever in Egypt (22).  The donors, who 
were ill with sand-fly fever when the blood was drawn, showed no signs at that time of jaun- 
dice and the icterogenic capacity of the blood was a chance finding,  s  This icterogenic agent or 
virus has now been through four passages in human  volunteers.  It withstands heating to 
56°C. for at least 30 minutes.  It has produced clin/cal jaundice in 14 out of 31 b-m~n volun- 
teers, inoculated parenterally, with incubation periods ranging from 56 to 134 days.  Experi- 
mental subjects convalescent from this type of hepatitis produced by this agent are not immune 
to experimental re-infection as induced by the strain of infectious hepatitis used in this labors- 
tory (3). 
Laboratory Observat~a.~AU  volunteers were inoadsted on the same day.  Starting 60 
days after inoculation the following tests of liver function were performed every 2 weeks (or 
more often) until the end of the period of observation:  (1) quantitative total serum bilirubin;* 
(2) cephalin-cholesterol focculation (Hanger) (23); and (3) thymol turbidity test (24).  If the 
cephalin focculation or thymol turbidity test became positive, bromsulfaiein dye retention  t 
was estimated.  Only volunteers who had symptoms and signs of homologous serum jaundice 
in conjunction with consistently abnormal cephalin-cholesterol flocculation and/or bromsulfa- 
Iein dye retention were regarded as positive cases.  In this study an positive cases had clinical 
jaundice, 
EXPERrgf~NTAL 
Materials for testing employed in this experiment were pools of serum and stools obtained 
at various times during the incubation period and course of disease of 3 volunteers with ex- 
perimentally induced homologous serum jaundice.  These men had contracted homologous 
serum jaundice experimentally 56, 66, and 70 (average 64) days respectively after parenteral 
inoculation of the strain of homologous serum jaundice used  in  this  laboratory.  All 3 pa- 
tients had clinical jaundice with a mild course of disease (21).  Serum was collected from each 
man:  (a) three-fourths through  the incubation period, (b) during the flrsg week of disease, (¢) 
and in the con~al~cent period 28 to 32 days after onset.  Stools were collected in theflrst week 
of disease.  Acute phase stools and sera were collected from the same patient on the same day. 
All specimens were stored at dry-ice box temperature for a period of 14 to 15 months.  Before 
use all material was thawed at room temperature.  Equal amounts of the same material from 
each patient were pooled and treated in the following manner: serum was heated to 56°C. for 
30 minutes in a water bath to eliminate bacteria; stools were ground with sterile alundum and 
suspended in enough sterile 10/u buffered sodium phosphate to make a 10 per cent suspension. 
This was centrifuged at 1500 R.P.u.  for 15 minutes at room temperature to remove coarse 
particles.  The supernate was removed and centrifuged at 6500 l.p.u, for 30 minutes at room 
temperature.  This fairly clear supernate was removed and filtered through a Seitz EK filter 
at a pH of 7.0.  The filtrate was then heated to 56°C. for 30 minutes in a water bath. s  Both 
serum and filtrates of stool were sterile.  Before administration the serum was diluted 1:3 
with sterile 10/K buffered sodium phosphate and the stool filtrates were diluted with 30 cc. of 
tap water. 
i Of the 11 men whose blood went into this pool, 10 were followed for s period of 4 months. 
None of them reported having had jaundice.  The eleventh man had left the country and 
eould not be traced. 
s According to the method of Malloy and Evelyn (25) using the photoelectric colorimeter. 
4 10 per cent retention of dye in the blood 30 minutes after the intravenous injection of 5 
mg./kg, of body weight was considered maximum normal. 
s Stool extracts are prepared  (heating and filtration) in this manner in order to eliminate 
bscterls.  This treatment does not eliminate the virus of infectious hepatitis from stools (1). 444  PERIOD  01~  INFECTIVITY  0~'  HOMOLOGOUS  SERUM  JAENDICE 
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FIO. 1.  Illustration of results of administration to human volunteers of pools of 
serum and stool obtained three-fourths through (48th day) the incubation period and 
during the acute (4 to 8th day) and convalescent (28 to 32nd day) phases of 3 patients 
with experimentally induced homologous serum jaundice.  The horizontal bar in the 
middle of the diagram indicates the general course of the 3 patients who were donors of 
the  nmterial to be tested.  Incubation  periods of the  donors were 56,  66,  and  70 
(average 64)  days respectively.  Serum was obtained from each man three-fourths 
through his respective incubation period  (average 48 days).  Open circles indicate 
volunteers who were inoculated and failed to contract the disease;  black circles indi- 
cate volunteers who contracted homologous  serum jaundice.  The figure  adjacent 
to the black circle represents the length of incubation period in days. 
TABLE  I 
Data on 4 Human  Voluntetra with Homologous Strum Jaundice Exptrlmentally  Induced by 
Par~ttral  Inoculation  of  0.16 M1.  of  Icttrogenl¢ Strum 
VolUn- 
teer 
KY 
HY 
KI 
BK 
i  Source of inoculum* 
I 
i 
Incubation  period  (3 patients) 
4th-8th day disease (3 patients) 
¢i  is  ~i  #4  ~t  i¢ 
Duration days 
Incu- 
bation 
period 
Joys 
6O 
71 
60 
66 
Maximum 
Fever  Jaun-  Fever  dice 
days  days  "F. 
8  30  101.0 
0  10  98.6 
7  26  99.6 
14  60  99.4 
Seru~ 
bill- 
rsxblu 
mg, 
per c¢~J 
17 
3.9 
6.3 
4O 
Severity 
+.-I-+ 
÷ 
++ 
+-l-++ 
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• The small number of tests that can be performed in experimentation of this 
type, limit the statistical value of the results.  Nevertheless, the positive re- 
suits are significant and the negative ones less so.  In brief the results were as 
follows: 29 human volunteers were fed or inoculated with the stool filtrates or 
serum to be tested.  Serum obtained both during the incubation period and 
during the first week of disease (and heated as above described) was infectious 
on sub- and intracutaneous inoculation, producing the disease in 4 out of 8 
human volunteers.  The same serum when fed to 10 other volunteers failed to 
produce  clinical disease or deflection of  liver function  tests.  Acute phase 
stools when fed and convalescent phase serum when inoculated sub- and intra- 
cutaneously were  apparently not infectious (Fig.  1).  Certain  salient facts 
about the clinical course of disease of the 4  patients who contracted serum 
jaundice experimentally are recorded in Table L 
DISCUSSION 
The results are based upon a single experiment performed with one strain of 
homologous serum jaundice.  One should not generalize too far about these 
results.  However, in so far as the experiment goes, it substantiates the assump- 
tion that certain differences exist between homologous serum jaundice and 
infectious hepatitis.  These differences are apparent in relation to the period 
of infectivity of the blood, the effective route of inoculation, and the presence 
or absence of the virus in the feces. 
Attention has already been drawn in this paper to an earlier observation (2) 
from this same laboratory, in which the serum of a human volunteer inoculated 
experimentally with the virus of homologous serum jaundice was found to con- 
tain virus 34 days later and 60 days before onset of his disease.  Little else has 
been known as to when the virus appears in the blood or how long it remains 
there. 
In the present communication virus has been demonstrated experimentally 
from a serum pool collected from 3 patients three-fourths through their respec- 
tive 56, 66, and 70 day incubation periods and again during the acute phase of 
disease.  There was insufficient virus in the convalescent phase serum of these 
same patients to produce infection when inoculated into human volunteers. 
It may be pointed out here that the presence of virus in the serum both one- 
third and three-fourths through the long incubation period of patients with 
homologous serum  jaundice,  may,  if substantiated  by further experiments, 
constitute a difference between this condition and infectious hepatitis in which 
one attempt to demonstrate virus midway through the short incubation period 
of a single patient has been unsuccessful (1).  This difference might be based 
on the fact that the incubation period of serum jaundice is generally so much 
longer than that of infectious hepatitis.  It is possible that for the first 20 to 30 445  PERIOD  OF  INFECTIVITY  OF  HOMOLOGOUS SERUM  JAUNDICE 
days of the incubation period the blood stream might be free of virus in both 
diseases but that in serum jaundice there is a subsequent long (30 to 150 day) 
period of viremia preceding the development of hepatitis.  This has a bearing 
on the choice of donors for transfusions since an apparently healthy person may 
carry the virus of homologous serum jaundice in the blood for a long period and 
thereby constitute a menace. 
Pooled specimens of feces obtained from 3 patients in the acute phase of 
homologous serum jaundice when virus was demonstrated to be present in the 
serum failed to produce the disease when fed to volunteers.  Moreover, serum 
from the incubation period and acute phase of disease, which was proven to be 
infectious by patenteral inoculation, failed to produce disease when ingested. 
This is another difference between our two strains of homologous serum jaun- 
dice and infectious hepatitis.  In the latter conditl"on virus has been found in 
the stools and also the disease has been produced experimentally by feeding 
infectious serum.  These facts suggest: (1) that invasion of the blood occurs 
during the long incubation period of homologous serum jaundice; (2) that in 
convalescence virus has not been demonstrated, and its absence may be the 
result of some form of neutralization which may occur by the 4th week of dis- 
ease; (3) the failure to demonstrate virus in the stools of patients with homolo- 
gous serum jaundice as well as the failure to transmit this disease by feeding 
known infectious material suggests that the intestinal-oral route is not of impor- 
tance in the spread of homologous serum jaundice.  This constitutes another 
difference experimentally, at least, from infectious hepatitis. 
SUMMARY 
1.  Pooled specimens of serum  obtained  from  3  human  volunteers  three. 
fourths  through  their  respective 56,  66,  and  70  day  incubation  periods of 
homologous serum jaundice produced the disease in 1 out of 4 human volun- 
teers following parenteral inoculation. 
2.  Serum specimens obtained from these same 3 patients during the acute, 
pre-icteric phase of their homologous serum jaundice produced the disease in 
3 out of 4 human volunteers following parenteral inoculation. 
3.  These same sera, proven to be infectious by parenteral inoculation, failed 
to produce disease when ingested by 10 other human volunteers. 
4.  Pooled specimens of serum obtained in the convalescent phase (28 to 32 
days after onset) of these 3 patients failed to produce apparent infection when 
inoculated parenterally into 5 human volunteers. 
5.  Pooled specimens of feces of 3 patients obtained in the acute phase of 
homologous serum jaundice, when virus was proven to be in the serum, were not 
demonstrably infectious when fed to 6 volunteers. 
6.  These findings  are slightly different from those encountered in a  similar 
study with infectious material from cases of infectious hepatitis. W.  PAUL  HAVENS,  JR.  447 
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